Cargando…
Food Bioactive HDAC Inhibitors in the Epigenetic Regulation of Heart Failure
Approximately 5.7 million U.S. adults have been diagnosed with heart failure (HF). More concerning is that one in nine U.S. deaths included HF as a contributing cause. Current HF drugs (e.g., β-blockers, ACEi) target intracellular signaling cascades downstream of cell surface receptors to prevent ca...
Autores principales: | Evans, Levi W., Ferguson, Bradley S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115944/ https://www.ncbi.nlm.nih.gov/pubmed/30126190 http://dx.doi.org/10.3390/nu10081120 |
Ejemplares similares
-
The Crosstalk between Acetylation and Phosphorylation: Emerging New Roles for HDAC Inhibitors in the Heart
por: Habibian, Justine, et al.
Publicado: (2018) -
Targeting Epigenetic Regulators with HDAC and BET Inhibitors to Modulate Muscle Wasting
por: Nevi, Lorenzo, et al.
Publicado: (2023) -
HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases
por: Hull, Elizabeth E., et al.
Publicado: (2016) -
Epigenetics and Heart Failure
por: Ameer, Syeda Shegufta, et al.
Publicado: (2020) -
Epigenetics: a new mechanism of regulation of heart failure?
por: Papait, Roberto, et al.
Publicado: (2013)